Fighting Antimicrobial-Resistant HAIs
Diagnostics are key to preventing and controlling this growing global threat.
Read MorePosted by Laurie Bonner | Oct 27, 2020 | Infectious Diseases, Microbiology |
Diagnostics are key to preventing and controlling this growing global threat.
Read MorePosted by Laurie Bonner | Oct 27, 2020 | Diagnostic Technologies |
The E-Nose Breathanalyzer will have the capability of analyzing compounds found within a person’s breath to diagnose a battery of illnesses and abnormalities including respiratory illnesses, infectious diseases, and cardiovascular conditions.
Read MorePosted by Laurie Bonner | Oct 23, 2020 | Molecular Diagnostics, Womens Health |
Two FDA-approved molecular testing platforms are leading to better targeted treatments for this common infection.
Read MorePosted by Laurie Bonner | Oct 22, 2020 | Covid 19, Molecular Diagnostics |
The test is designed to detect respiratory co-infections as well as antibiotic-resistant pathogens in patients with SARS-CoV-2.
Read MorePosted by Laurie Bonner | Oct 21, 2020 | Company News, Digital Pathology |
End-to-end transformation will enable groundbreaking biomedical research, advance precision medicine initiatives, and improve routine diagnosis.
Read More